Intra-tumoral distribution of 64Cu-ATSM: A comparison study with FDG

Nuclear Medicine and Biology

Volumn 30, Issue 5, 2003, Pages 529-534

  Obata, Atsushi ^a,b   Yoshimoto, Mitsuyoshi ^c   Kasamatsu, Shingo ^b   Naiki, Hironobu ^b   Takamatsu, Shinji ^b   Kashikura, Kenichi ^b   Furukawa, Takako ^b   Lewis, Jason S ^d   Welch, Michael J ^d   Saji, Hideo ^a   Yonekura, Yoshiharu ^b   Fujibayashi, Yasuhisa ^b  

^a KYOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF FUKUI   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

64Cu ATSM; Auoradiography; FDG; Hypoxia; Tumor; VX2

Indexed keywords

BIS(N 4 METHYLTHIOSEMICARBAZONE); COPPER 64; FLUORODEOXYGLUCOSE; SEMICARBAZONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CANCER TISSUE; CELL DEATH; CONTROLLED STUDY; CYTOLOGY; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG UPTAKE; HISTOLOGY; MALE; MICROSCOPY; NONHUMAN; RABBIT; TISSUE DISTRIBUTION; TUMOR CELL;

EID: 12444338955     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(03)00047-7     Document Type: Article

References (22)

1. Burk D., Woods M., Hunter J. On the significance of glucolysis for cancer growth, with special reference to Morris rat hepatomas. J. Natl. Cancer Inst. 38:1967;839-863.
2. Coleman C.N. Hypoxia in tumors a paradigm for the approach to biochemical and physiologic heterogeneity . J. Natl. Cancer Inst. 80:1988;310-317.
3. Chao K.S., Bosch W.R., Mutic S., Lewis J.S., Dehdashti F., Mintun M.A., Dempsey J.F., Perez C.A., Purdy J.A., Welch M.J. A novel approach to overcome hypoxic tumor resistance Cu-ATSM-guided intensity-modulated radiation therapy . Int. J. Radiat. Oncol. Biol. Phys. 49:2001;1171-1182.
4. Fujibayashi Y., Matsumoto K., Yonekura Y., Konishi J., Yokoyama A. A new zinc-62/copper-62 generator as a copper-62 source for PET radiopharmaceuticals. J. Nucl. Med. 30:1989;1838-1842.
5. Fujibayashi Y., Taniuchi H., Yonekura Y., Ohtani H., Konishi J., Yokoyama A. Copper-62-ATSM a new hypoxia imaging agent with high membrane permeability and low redox potential . J. Nucl. Med. 38:1997;1155-1160.
6. 18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J. Nucl. Med. 27:1986;235-238.
7. 4-methylthiosemicarbazone) An agent for radiotherapy . Proc. Natl. Acad. Sci. USA. 98:2001;1206-1211.
8. 64 Cu-ATSM in vitro and in vivo in a hypoxic tumor model. J. Nucl. Med. 40:1999;177-183.
9. Lewis J.S., Sharp T.L., Laforest R., Fujibayashi Y., Welch M.J. Tumor uptake of copper-diacetyl-bis(N(4)-methylthiosemicarbazone) effect of changes in tissue oxygenation . J. Nucl. Med. 42:2001;655-661.
10. McCarthy D.W., Bass L.A., Cutler P.D., Shefer R.E., Klinkowstein R.E., Herrero P., Lewis J.S., Cutler C.S., Anderson C.J., Welch M.J. High purity production and potential applications of copper-60 and copper-61. Nucl. Med. Biol. 26:1999;351-358.
11. 64Cu using a biomedical cyclotron. Nucl. Med. Biol. 24:1997;35-43.
12. Minn H., Joensuu H., Ahonen A., Klemi P. Fluorodeoxyglucose imaging a method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumors . Cancer. 61:1988;1776-1781.
13. 64Cu using a 12 MeV cyclotron., Nucl. Med. Biol. in press.
14. 4-methylthiosemicarbazone) (Cu-ATSM) in tumor cells. Ann. Nucl. Med. 15:2001;499-504.
15. Okada J., Yoshikawa K., Itami M., Imaseki K., Uno K., Itami J., Kuyama J., Mikata A., Arimizu N. Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma a comparison with proliferative activity . J. Nucl. Med. 33:1992;325-329.
16. Peters L.J., Withers H.R., Thames H.D. Jr., G.H. Fletcher, Tumor radioresistance in clinical radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 8:1982;101-108.
17. Rajs J., Harm T. Isolated rat cardiac myocytes as an experimental tool in the study of anoxic cell injury. Effect of reoxygenation-a preliminary report. Forensic Sci. Int. 16:1980;185-190.
18. 4-methylthiosemicarbazone) as a hypoxic tissue tracer in patients with lung cancer. Ann. Nucl. Med. 14:2000;323-328.
19. Takahashi N., Fujibayashi Y., Yonekura Y., Welch M.J., Waki A., Tsuchida T., Sadato N., Sugimoto K., Nakano A., Lee J.D., Itoh H. Copper-62 ATSM as a hypoxic tissue tracer in myocardial ischemia. Ann. Nucl. Med. 15:2001;293-296.
20. Taniuchi H., Fujibayashi Y., Yonekura Y., Konishi J., Yokoyama A. Hyperfixation of copper-62-PTSM in rat brain after transient global ischemia. J. Nucl. Med. 38:1997;1130-1134.
21. Tannock I., Guttman P. Response of Chinese hamster ovary cells to anticancer drugs under aerobic and hypoxic conditions. Br. J. Cancer. 43:1981;245-248.
22. Teicher B.A., Holden S.A., al-Achi A., Herman T.S. Classification of antineoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in vivo in the FSaIIC murine fibrosarcoma. Cancer Res. 50:1990;3339-3344.